Tag: NIH funding

Are Businesses Eligible for Research Grants Outside of the SBIR/STTR Program?

Did you know that businesses are eligible for federal research grants too?

Most folks know that government research grant funding powers academic research, but did you know that businesses are eligible for research grants too? Grant funding is non-dilutive, meaning the small business does not have to give the funding agency a share of the business, as it would venture capitalists. While most entrepreneurs are aware of their eligibility for SBIR/STTR funding, many are unaware they qualify for many other agency-funded opportunities as well.

[Read: How to Find Research Funding Opportunities: A Quick Start Guide]

Grant funding has been the coin of the realm in academic research for decades, and most of the funding in the mechanisms traditionally associated with academic research, e.g., the NIH R01, still flows into these institutions. In return for this funding, researchers are required to submit reports on their progress and spending and are expected (or required) to share their final outcomes with their peers and the public as appropriate.

What many small businesses don’t know is that they, too, are often eligible for these funding mechanisms. Today I reviewed the posted grant and cooperative agreement opportunities offered by the National Science Foundation (NSF) and the agencies within the Department of Health and Human Services (HHS) that support a lot of research—Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), and Substance Abuse and Mental Health Services Administration (SAMHSA). This is not a scientific survey, just a snapshot in time, but it is worth noting that, of the 1,474 total opportunities available, small businesses were eligible for 1,118 (76%) and businesses that don’t qualify as a small business were eligible for 1,022 (69%)! Perhaps most surprising was that in this sample businesses were eligible for more funding opportunities than academic research institutions, and these opportunities ranged from research grants to center grants and cooperative agreements (and, of course, SBIR/STTR funding opportunities).

The upshot here is, if you are a business owner in need of some R&D funding and you haven’t considered the many non-dilutive funding opportunities available to you from government agencies, you should. If you are a global entrepreneur, there are great non-dilutive funding opportunities available to you outside of the US as well.

[Read: Non-Dilutive Funding Opportunities for Global Entrepreneurs]

Updated: 27 June 2019

Like What You See?

This article was published in the March issue of Strategic Grantsmanship News, a newsletter distributed monthly to subscribers to the Strategic Grantsmanship mailing list. If you like what you see and would like to learn more about how to win more grants in less time, then this is the list for you. Click here to join the mailing list!

Post-submission Strategy, Revisited

Last week, the NIH Office of Extramural Research posted a brief blog entry about the submission of patent citations post-submission. However, I found the blog entry left out a key bit of strategy that I share with you here.

Last week, the NIH Office of Extramural Research (the office that handles funding for researchers external to the NIH, which has its own intramural scientists and funding opportunities as well) posted a brief blog entry about the submission of patent citations post-submission (meaning, after the application has already been submitted) in its Extramural Nexus blog. However, I found the blog entry left out a key bit of strategy that I thought I would share with you here. Continue reading “Post-submission Strategy, Revisited”

4 Quick Ways to Catch up on Critical Changes to Federal Grant Applications and Processes

The new year is a great time to recommit to your funding pursuit and do some deep work on crafting a funding strategy and drafting some proposals, but that energy will be misspent if you haven’t spent some time catching up with NIH policies effective in the new year. So here are 4 great sources for news everyone applying for funding should know.

Updated 12 December 2017.

Just a quick reminder to everyone to set some time aside over the holidays to review changes to NIH policy (e.g., clinical trials) before drafting a funding strategy for 2018. The new year is a great time to recommit to your funding pursuit and do some deep work on crafting a funding strategy and drafting some proposals, but that energy will be misspent if you haven’t spent some time catching up with NIH policies effective in the new year. So here are 4 great sources for news everyone applying for funding should know. Continue reading “4 Quick Ways to Catch up on Critical Changes to Federal Grant Applications and Processes”

More Changes to Funding at NIH to Benefit Researchers

Shrinking pools of research funding, lower success rates, and increasing resource scarcity at research institutions strain most researchers, but new researchers have had a particularly difficult time securing funding of late and many have left the field as a result. The NIH has signaled awareness of these pressures, announcing in April changes to the biosketch form that benefit new researchers and the replacement of the onerous “one resubmission” rule with a more relaxed policy.

Today, Dr. Sally Rockey and Dr. Francis Collins announced that the NIH would allow its centers and programs to offer longer, sustained funding to researchers in the model of the Howard Hughes Medical Institute’s (HHMI) “people, not projects” funding model. Continue reading “More Changes to Funding at NIH to Benefit Researchers”

In Case You Missed It: NIH Amends Resubmission Policy

In 2009, the NIH restricted the number of resubmissions of applications for funding to one (A1), requiring any subsequent new research funding applications (A0) to be substantially different from the unfunded application. Shrinking research budgets and the impacts of this restriction–it requires researchers to substantially re-direct their work, which may mean reorienting the efforts of a whole lab–were taking an obvious toll on research, with many meritorious ideas being abandoned as a result of this restriction. Continue reading “In Case You Missed It: NIH Amends Resubmission Policy”